The Experimental Medicine Training Initiative (EMI) is an exciting, new strategic scheme, supported by the University of Cambridge in partnership with the Cambridge University Hospitals, NIHR Cambridge Biomedical Research Centre and Industry Partners AstraZeneca/MedImmune and GSK, designed to build capacity in Experimental Medicine (EM).
EMI runs a series of training events which include discussions, interactive sessions and small group work to facilitate learning and training in drug development activities, particularly pre-clinical phase 3 and licensing. Industry partners deliver talks and lead on discussions.
